Long-term efficacy, safety, and predictors of response to amivantamab among patients with post-platinum EGFR Ex20ins-mutated advanced NSCLC
Document Type
Abstract
Publication Date
3-29-2023
Keywords
oregon; chiles
Abstract
ELCC Conference; March 29; Copenhagen Denmark. 2023: 30.
Area of Special Interest
Cancer
Specialty/Research Institute
Oncology
Comments
Lopez PG, Girard N, Cho BC, Sabari J, Spira A, Sanborn RE, Goto K, Yang JC, Curtin J, Lyu X, He A, Penton J, Edwards J, Massin GL, Xia K, Chioda M, Thayu M, Knoblauch RE, Mahadevia P, Leighl N